V

Veracyte

VCYT

22.940
USD
-1.04
(-4.34%)
Market Open
Volume
24,315
EPS
0
Div Yield
0
P/E
-44
Market Cap
2,506,379,606
Related Instruments
A
ALNY
31.19
(13.13%)
268.66 USD
A
ARWR
-1.160
(-4.06%)
27.410 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
GILD
0.470
(0.62%)
76.510 USD
I
ILMN
-0.250
(-0.20%)
122.370 USD
N
NVTA
0
(0%)
0.000000 USD
REGN
13.14
(1.22%)
1,091.19 USD
T
TDOC
-0.85000
(-9.00%)
8.59000 USD
V
VCYT
-1.040
(-4.34%)
22.940 USD
News

Title: Veracyte

Sector: Healthcare
Industry: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.